Heligenics & The Jackson Laboratory Announce New Collaboration on ERBB2 Breast Cancer Gene
Includes licensing of custom Heligenics Gene Mutation/Function ERBB2 library for the JAX Clinical Knowledgebase
News provided by
Share this article
Share this article
LAS VEGAS, May 11, 2021 /PRNewswire/ Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory (JAX). This joint project will make available the functional output of Variants of Unknown Significance (VUS) throughout key portion of the
ERBB2 gene through the JAX Clinical Knowledgebase (CKB), a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles.